APRE
Aprea Therapeutics Inc
Sign up for free!
Get instant access to stock market data and news with our free APIs.
Real-time data
- Listing exchange
- NASDAQ Stock Exchange
- Price
- $0.47
- Day High
- $0.48
- Day Low
- $0.47
- Day Open
- $0.48
- Volume
- 96
- Day Change
- -6.38%
Latest news data for APRE
Aprea Therapeutics Appoints John Hamill as Chief Financial Officer
globenewswire.com
Aprea Therapeutics to Participate in 6th Annual DNA Damage and Response (DDR) Inhibitors Summit
globenewswire.com
Karolinska Development’s portfolio company Aprea Therapeutics doses the first patient in a clinical phase 1/2a study of ATRN-119
globenewswire.com
Best Penny Stocks To Buy? 4 To Watch In January 2023
pennystocks.com
Aprea Therapeutics Reports Third Quarter 2022 Financial Results and Provides Update on Business Operations
globenewswire.com
Head-To-Head Survey: Aprea Therapeutics (NASDAQ:APRE) & Corvus Pharmaceuticals (NASDAQ:CRVS)
etfdailynews.com
Aprea Therapeutics, Inc. (NASDAQ:APRE) Short Interest Update
etfdailynews.com
Vor Bio Appoints Eyal C. Attar, M.D. as Chief Medical Officer
globenewswire.com
Aprea Therapeutics (NASDAQ:APRE) Receives Buy Rating from HC Wainwright
etfdailynews.com
Aprea Therapeutics, Inc. (NASDAQ:APRE) Sees Large Growth in Short Interest
etfdailynews.com